
Loading, please wait...

Loading, please wait...

Diagnosing tuberculosis has long depended on sputum samples. However, many vulnerable patients like children and the elderly struggle to produce sputum. Fortunately, a revolutionary tongue-swab TB test may soon transform decentralized diagnostics across India. A landmark international study published in the New England Journal of Medicine (NEJM) validated the battery-operated MiniDock MTB platform. Specifically, this near-point-of-care test delivers rapid results within 12 to 25 minutes.
The clinical trial evaluated the performance of the MiniDock MTB platform across seven countries, including India. Consequently, researchers analyzed samples from 1,380 participants. The test achieved an impressive 85.7% sensitivity using sputum swabs. Furthermore, it achieved 79.6% sensitivity using non-invasive tongue swabs. In addition, the specificity remained remarkably high for both sampling methods. Therefore, this platform meets the World Health Organization (WHO) target product profiles for rapid diagnostics.
Traditional diagnostic methods like smear microscopy often miss active cases. In contrast, nucleic acid amplification tests (NAATs) offer superior accuracy. The MiniDock MTB functions as a highly affordable NAAT. Thus, it can easily expand testing access in resource-limited, peripheral healthcare settings. Additionally, clinicians can bypass logistically complex options like X-rays, avoiding radiation risks entirely. Indigenous platforms like Molbio's Truenat are also adapting to support tongue-swab specimens, aligning with India's national TB elimination goals.
Q1: What is the main advantage of the tongue-swab TB test?
The tongue-swab test provides a non-invasive, painless alternative to sputum collection. Consequently, it is ideal for pediatric, elderly, and HIV-positive patients who struggle to cough up sputum.
Q2: How fast does the MiniDock MTB deliver results?
The battery-operated MiniDock MTB platform utilizes molecular amplification to provide highly accurate diagnostic results in just 12 to 25 minutes.
Q3: Does the tongue-swab TB test meet global diagnostic standards?
Yes. Although tongue swabs are slightly less sensitive than sputum, the test easily meets the diagnostic accuracy standards set by the World Health Organization (WHO).
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


A landmark study validates the portable MiniDock MTB tongue-swab TB test in India, showing high accuracy and enabling faster diagnosis near the point of car...
4 months ago

Explore vital recurrent stroke predictors in lacunar stroke patients managed with intensive blood pressure lowering. This analysis examines trial findings from SPS3 to uncover residual vascular risks, metabolic factors, and targeted secondary prevention strategies for high-risk neurological patients.
Today

A comprehensive scoping review synthesises evidence linking prenatal maternal mental health to long-term offspring neurodevelopment, evaluating neuroendocrine, inflammatory, and epigenetic pathways while highlighting clinical screening and future research priorities.
Today

The Directorate General of Health Services directs Indian states to halt the hazardous reuse and reprocessing of single-use medical devices. Discover regulatory implications under the Drugs and Cosmetics Act, critical infection risks, legal liabilities, and operational changes required across clinical specialties.
Today

Mitochondria-targeted nanoparticles self-assembled from EGCG and L-glutamic acid effectively restore mitochondrial homeostasis, suppress synovial inflammation, and attenuate chondrocyte senescence in osteoarthritis, offering a promising disease-modifying nanotherapy.
Today

India is advancing preventive healthcare by integrating genomics, artificial intelligence, and quantum technologies. With the SANGAM programme sequencing one million Indian genomes, clinicians can unlock personalized therapies, detect cardiometabolic risks early, and curb the burden of diabetes and heart disease.
Today